期刊文献+

The emerging role of probiotics in neurodegenerative diseases:new hope for Parkinson’s disease? 被引量:2

下载PDF
导出
摘要 Neurodegenerative disease etiology is still unclear,but different contributing factors,such as lifestyle and genetic factors are involved.Altered components of the gut could play a key role in the gut-brain axis,which is a bidirectional system between the central nervous system and the enteric nervous system.Variations in the composition of the gut microbiota and its function between healthy people and patients have been reported for a variety of human disorders comprising metabolic,autoimmune,cancer,and,notably,neurodegenerative disorders.Diet can alter the microbiota composition,affecting the gutbrain axis function.Different nutraceutical interventions have been devoted to normalizing gut microbiome dysbiosis and to improving biological outcomes in neurological conditions,including the use of probiotics.Preclinical and clinical investigations discussed in this review strengthen the correlation between intestinal microbiota and brain and the concept that modifying the microbiome composition may improve brain neurochemistry,modulating different pathways.This review will discuss the potential use of probiotics for Parkinson’s disease prevention or treatment or as adjuvant therapy,confirming that gut microbiota modulation influences different pro-survival pathways.Future investigations in Parkinson’s disease should consider the role of the gut-brain axis and additional comprehension of the underlying mechanisms is extremely necessary.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2021年第4期628-634,共7页 中国神经再生研究(英文版)
  • 相关文献

参考文献3

二级参考文献52

  • 1Rodrigo R, Cauli O, Gomez-Pinedo U, Agusti A, Hernandez-Rabaza V, Garcia-Verdugo JM, Felipo V. Hyperammonemia induces neuro- inflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology, 2010, 139: 675-684. 被引量:1
  • 2Saul WSWB. Hyperammonemic encephalopathy. Medicine (Abing- don), 2002, 81: 240-249. 被引量:1
  • 3Felipo V, Butterworth RF. Neurobiology of ammonia. Prog Neurobiol, 2002, 67: 259-279. 被引量:1
  • 4Lajtha A, Reith MEA, eds. Handbook of Neurochemistry and Molecular Neurobiology. 3rd ed. New York: Springer, 2008. 被引量:1
  • 5Basile AS, Jones EA. Ammonia and GABA-ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology, 1997, 25: 1303-1305. 被引量:1
  • 6Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, Felipo V. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol, 2009, 43: 272-279. 被引量:1
  • 7Gibertini M, Newton C, Friedman H, Klein TW. Spatial learning impairment in mice infected with legionella pneumophila or administered exogenous interleukin-1β. Brain Behav Immun, 1995, 9: 113-128. 被引量:1
  • 8Wiltfang J, Nolte W, Wei?enborn K, Komhuber J, Rüther E. Psychiatric aspects of portal-systemic encephalopathy. Metab Brain Dis, 1998, 13: 379-389. 被引量:1
  • 9Erecinska M, Pastuszko A, Wilson DF, Nelson D. Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids. J Neurochem, 1987, 49: 1258-1265. 被引量:1
  • 10R?ssle M, Luft M, Herz R, Klein B, Lehmann M, Gerok W. Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution. Klin Wochenschr, 1984, 62: 867-875. 被引量:1

共引文献57

同被引文献21

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部